Answers are grounded in this paper and cite their sources.
Sickle cell disorders are among the most common hemoglobinopathies worldwide. Early detection is essential to reduce complications and to facilitate prenatal diagnosis of sickle cell disorders. Our aim is to report the frequency, clinico-hematological, and molecular profiles of patients with sickle cell disorders in Pakistan. This retrospective study included patients with sickle cell disorders from 2009 to 2024 at the Armed Forces Institute of Pathology, Pakistan. Patients were diagnosed based on results of high-performance liquid chromatography (HPLC), capillary electrophoresis, and polymerase chain reaction (PCR). Data were analyzed using IBM Statistical Package for the Social Sciences (SPSS) version 26. This study comprised 227 patients with sickle cell disorders, of whom 147 (64.8%) were male. The most common clinical manifestation was pallor, observed in 118 (52%) patients. The mean age was 17.99 ± 12.67 years. The spectrum of sickle cell disorders included heterozygous HbS (sickle cell trait) in 101 (44.5%), homozygous HbS consistent with sickle cell disease in 54 (23.8%) patients, sickle-β thalassemia in 68 (30%), HbS/D in 2 (0.9%), and HbS/E in one patient (0.44%). Among patients with sickle-β thalassemia, the most common variant was the Fr 8-9 frameshift insertion between codons 8 and 9 of the β-globin gene, seen in 11 of 34 (32.3%) patients, followed by the codon 15 (G→A) mutation (26%). A variety of sickle cell disorders are prevalent in our region. Timely identification, especially through molecular analysis, is essential to reduce associated complications and to facilitate prenatal diagnosis.
No takes yet. Share an insight, caveat, or question.
Mahmood et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: